Abstract
There is no abstract for this article.
Recommended Citation
AL-Tweigeri, Taher
(2023)
"Fam-Trastuzumab Deruxtecan (Enhertu) Induced pyloric perforation in hormonal receptor positive/ HER2 low express metastatic breast cancer.,"
Hematology/Oncology and Stem Cell Therapy: Vol. 17
:
Iss.
1
, Article 9.
Available at: https://doi.org/10.56875/2589-0646.1105
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Included in
Cancer Biology Commons, Hematology Commons, Oncology Commons